Bax and Bid act in synergy to bring about T11TS-mediated glioma apoptosis via the release of mitochondrial cytochrome c and subsequent caspase activation

International Immunology

Volumn 20, Issue 12, 2008, Pages 1489-1505

  Bhattacharjee, M ^a   Acharya, S ^a   Ghosh, A ^a   Sarkar, P ^a   Chatterjee, S ^a   Kumar, P ^a   Chaudhuri, Swapna ^a  

^a CALCUTTA SCHOOL OF TROPICAL MEDICINE   (India)

Author keywords

Bax; Bid; Brain infiltrating lymphocytes; Glioma; Microglia

Indexed keywords

APOPTOTIC PROTEASE ACTIVATING FACTOR 1; CASPASE 3; CASPASE 9; CYTOCHROME C; MEMBRANE PROTEIN; PROTEIN BAX; PROTEIN BCL 2; PROTEIN BID; PROTEIN P53; PROTEIN T11TS; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL TYPE; CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVATION; ENZYME RELEASE; FEMALE; GLIOMA; GLIOMA CELL; IMMUNOCOMPETENT CELL; IMMUNOLOGY; LYMPHOCYTE; MALE; MICROGLIA; MITOCHONDRIAL MEMBRANE; NEWBORN; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; WESTERN BLOTTING;

ANIMALS; APOPTOSIS; APOPTOSOMES; APOPTOTIC PROTEASE-ACTIVATING FACTOR 1; BCL-2-ASSOCIATED X PROTEIN; BH3 INTERACTING DOMAIN DEATH AGONIST PROTEIN; CASPASES; CYTOCHROMES C; ENZYME ACTIVATION; ERYTHROCYTES; GLIOMA; LYMPHOCYTES, TUMOR-INFILTRATING; MEMBRANE GLYCOPROTEINS; MICROGLIA; MITOCHONDRIA; NITROSOUREA COMPOUNDS; RATS; SHEEP; SIGNAL TRANSDUCTION;

EID: 57049154820     PISSN: 09538178     EISSN: 14602377     Source Type: Journal    
DOI: 10.1093/intimm/dxn109     Document Type: Article

References (34)

1. Sarkar, S., Ghosh, A., Mukherjee, J., Chaudhuri, S. and Chaudhuri, S. 2004. CD2-SLFA-3/T11TS interaction facilitates immune activation and glioma regression by T11TS. Cancer Biol. Ther. 3:1121.
2. Mukherjee, J., Ghosh, A., Sarkar, P., Mazumdar, M., Banerjee, C. and Chaudhuri, S. 2005. Immunotherapy with T11TS/SLFA-3 specifically induces apoptosis of brain tumor cells by augmenting intracranial immune status. Anticancer Res. 25:2905.
3. Mukherjee, J., Ghosh, A., Sarkar, S. et al. 2005. T11TS/SLFA-3 induces apoptosis of the brain tumor cells: A new approach to characterize the apoptosis associated genetic changes by arbitrarily primed-PCR. Cancer Lett. 222:23.
4. Gross, A., Yin, X. M., Wang, K. et al. 1999. Caspase cleaved BID targets mitochondria and is required for cytochrome c release, while BCL-XL prevents this release but not tumor necrosis factor-R1/Fas death. J. Biol. Chem. 274:1156.
5. Han, Z., Bhalla, K., Pantazis, P., Hendrickson, E. A. and Wyche, J. H. 1999. Cif (cytochrome c efflux-inducing factor) activity is regulated by Bcl-2 and caspases and correlates with the activation of Bid. Mol. Cell. Biol. 19:1381.
6. Li, H., Zhu, H., Xu, C. J. and Yuan, J. 1998. Cleavage of BID by caspase 8 mediates the mitochondrial damage in the Fas pathway of apoptosis. Cell 94:491.
7. Luo, X., Budihardjo, I., Zou, H., Slaughter, C. and Wang, X. 1998. Bid, a Bcl-2 interacting protein, mediates cytochrome c release from mitochondria in response to activation of cell surface death receptors. Cell 94:481.
8. Desagher, S., Osen-Sand, A., Nichols, A. et al. 1999. Bid-induced conformational change of Bax is responsible for mitochondrial cytochrome c release during apoptosis. J. Cell Biol. 144:891.
9. Wang, K., Yin, X. M., Chao, D. T., Milliman, C. L. and Korsmeyer, S. J. 1996. BID: A novel BH3 domain-only death agonist. Genes Dev. 10:2859.
10. Yin, C., Knudson, C. M., Korsmeyer, S. J. and Van Dyke, T. 1997. Bax suppresses tumorigenesis and stimulates apoptosis in vivo. Nature 385:637.
11. McCurrach, M. E., Connor, T. M., Knudson, C. M., Korsmeyer, S. J. and Lowe, S. W. 1997. Bax-deficiency promotes drug resistance and oncogenic transformation by attenuating p53-dependent apoptosis. Proc. Natl Acad. Sci. USA 94:2345.
12. Mukhopadadyay, T., Maxwell, S. A. and Roth, J. A. 1995. Wildtype versus mutant p53. In Mukhopadadyay, T., Maxwell, S. A. and Roth, J. A., eds, Molecular Biology Intelligence Unit P53 Suppressor Gene, p. 19. Springer Verlag, New York. 19.
13. Marzo, I., Brenner, C. and Zamzami, N. 1998. Bax and adenine nucleotide translocator cooperate in the mitochondrial control of apoptosis. Science 281:2027.
14. Oltvai, Z. N., Korsmeyer, S. J. and Milliman, C. L. 1993. Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death. Cell 74:609.
15. Jiang, X. and Wang, X. 2000. Cytochrome c promotes caspase-9 activation by inducing nucleotide binding to Apaf-1. J. Biol. Chem. 275:31199.
16. Zou, H., Li, Y., Liu, X. and Wang, X. 1999. An Apaf-1.cytochrome c multimeric complex is a functional apoptosome that activates procaspase-9. J. Biol. Chem. 274:11549.
17. Rodriguez, J. and Lazebnik, Y. 1999. Caspase-9 and Apaf-1 form an active holoenzyme. Genes Dev. 13:3179.
18. White, A. C., McCombe, P. A. and Pender, M. P. 1990. Microglia are more susceptible than macrophages to apoptosis in the central nervous system in experimental autoimmune encephalomyelitis through a mechanism not involving Fas(CD95). Int. Immunol. 10:935.
19. Druckray, H., Ivancovic, S. and Preussman, R. 1966. Tetragenic and carcinogenic effects in the offspring after single injection of ethylnitrosourea to pregnant rats. Nature 210:1378.
20. Koestner, A., Swenberg, J. A. and Wechsler, W. 1971. Transplacental production with ethylnitrosourea of neoplasms of the nervous system in Sprague-Dawley rats. Am. J. Pathol. 63:37.
21. Lantos, P. L. 1993. Chemical induction of tumors in nervous system. In Thomas, G. T., ed., NeuroOncology, p. 85. Churchill Livingstone, New York, London. 85.
22. Mukherjee, J., Sarkar, S., Begurn, Z. et al. 2002. Preclinical changes in immunoreactivity and cellular architecture during the progressive development of intracranial neoplasm and its immunotherapeutic schedule with a novel biological response modifier, the T11TS/S-LFA-3. Asian Pac. J. Cancer Prev. 3:325.
23. Sarkar, S., Begum, Z., Dutta, S., Chaudhuri, S. and Chaudhuri, S. 2002. Sheep form of leucocyte function antigen 3 (T1ITS) exerts immunostimulatory and anti-tumor activity against experimental brain tumor: A new approach to biological response modifier therapy. J. Exp. Clin. Cancer Res. 21:95.
24. Mukherjee, J., Sarkar, S., Ghosh, A., Duttagupta, A. K., Chaudhuri, S. and Chaudhuri, S. 2004. Immunotherapeutic effects of T11TS/SLFA-3 against nitrosocompound mediated neural genotoxicity. Toxicol. Lett. 150:239.
25. Chattopadhyay, P., Rathore, A., Mathur, M., Sarkar, C., Mahapatra, A. K. and Sinha, S. 1997. Loss of heterozygosity of a locus on 17p13.3, independent of p53, is associated with higher grades of astrocytic tumors. Oncogene 15:871.
26. Westphal, M., Giese, A., Meissner, H. and Zirkel, D. 2001. Culture of cells from human tumors of the nervous system on an extracellular matrix derived from bovine corneal endothelial cells. In Pollard, J. W. and Walker, J. M., eds, Culture of Cells From Human Tumors of the Nervous System on an Extracellular Matrix Derived from Bovine Corneal Endothelial Cells, 2nd edn. Humana Press, New Jersey. 185.
27. Ando, H., Saio, M., One, N. and Tamakawa, N. 2002. B7.1 immunogene therapy effectively activates CD4+ tumor-infiltrating lymphocytes in the central nervous system in comparison with B7.2 gene therapy. Int. J. Oncol. 20:807.
28. Begum, Z., Ghosh, A., Sarkar, S. et al. 2004. Documentation of immune profile of microglia through cell surface marker study in glioma model primed by a novel cell surface glycopeptide T11TS/SLFA-3. Glycoconj. J. 20:515.
29. Fischer, H. and Reichmann, G. 2001. Brain dendritic cells and macrophage/ microglia in central nervous system inflammation. J. Immunol. 166:2717.
30. Begum, Z., Sarkar, S., Mukherjee, J., Ghosh, A., Chaudhuri, S. and Chaudhuri, S. 2003. Evaluation of anti-tumor property of specific and nonspecific BRMS in experimental glioma by assessing the microglial cell functional and phenotypic modulations. Cancer Biol. Ther. 2:356.
31. Martin, S. J., Reutelingsperger, C. P. and Mcgahon, A. J. 1995. Early redistribution of plasma membrane phosphatidylserine is a general feature of apoptosis regardless of the initiating stimulus: Inhibition by over expression of Bcl-2 and Abl. J. Exp. Med. 182:1545.
32. Vermes, I., Hannen, C., Steffens-Nakken, H. and Reutelingsperger, C. 1995. A novel assay for apoptosis. Flow cytometric detection of posphatidylserine expression on early apoptotic cells using fluorescence labelled Annexin-V. J. Immunol. Methods 180:39.
33. Sheets, E. E. and Yeh, J. 1997. The role of apoptosis in gynecological malignancies. Ann. Med. 9:121.
34. Diebold, J., Barretton, G. and Flechner, M. 1996. Bcl-2 expression, p53 accumulation and apoptosis in ovarian cancinomas. Am. J. Clin. Pathol. 105:341.